期刊文献+

重组Derp2变应原诱导小鼠变态反应气道炎症动物模型的建立 被引量:14

The development of a murine model of recombinant Derp2-induced allergic asthma
原文传递
导出
摘要 目的建立重组屋尘螨Derp2变应原(rDerp2)诱导的小鼠变态反应气道炎症动物模型。方法在大肠杆菌中诱导表达Derp2重组蛋白,用镍亲和柱层析法提纯重组蛋白;32只BALB/c小鼠随机分为屋尘螨粗浸液组(A组)、屋尘螨粗浸液+rDerp2组(B组)、rDerp2组(C组)、对照组(D组)。分别观察肺组织病理变化与支气管肺泡灌洗液(BLAF)中细胞学变化,采用酶联免疫吸附试验(ELISA)测定BLAF中和脾细胞培养上清IL-4与INF-γ变化,ELISA测定血清中IgE、IgG1与IgG2a抗体变化。结果成功表达、纯化Derp2重组蛋白;A、B、C组肺部病理改变呈现明显的变态反应性炎症;A、B、C组小鼠BALF中的细胞总数、淋巴细胞、中性粒细胞数和EOS计数显著高于D组(P<0.01);A、B、C组BALF中IL-4含量分别为(109.35±16.46)pg/ml、(88.87±5.66)pg/ml、(85.59±6.05)pg/ml,与D组(23.17±2.67)pg/ml相比差异有统计学意义(P均<0.01)。A、B、C组抗原特异性IgE抗体分别为0.49±0.04、0.41±0.02、0.37±0.04,与D组(0.03±0.01)相比差异有统计学意义(P均<0.01);A、B、C组小鼠脾细胞分泌IL-4分别为(266.20±19.18)pg/ml、(252.72±15.81)pg/ml、(243.62±19.07)pg/ml,与D组(15.99±1.56)pg/ml相比差异有统计学意义(P均<0.01)。结论用rDerp2能成功建立小鼠变态反应气道炎症动物模型。 Objective To develop a mouse model of allergic airway inflammation with recombinant house dust mite allergen (Derp2) as an allergen. Methods The recombinant Derp2 was expressed in Escherichia coli and purified through Ni^+ NTA His agarose. Thirty two BALB/c mice were randomly divided into crude mite extract group(group A, n = 8), rDerp2 + crude mite extract group(group B, n = 8), rDerp2 groups(group C, n = 8) and control groups(group D, n = 8). The mice were intranasally challenged after sensitization. Lungs were fixed in situ, processed and stained with haematoxylin and eosin. Differential cell counting of bronchoalveolar lavage fluid(BALF) was used to as indicator airway of inflammation. IL-4/INF-γ in BALF and antibody responses of IgE, IgG1 and IgG2a in serum were assessed with EIJSA. Cells from spleen were cultured for 24 h with rDerp2, and IL- 4/INF-γ in supernatants was measured by ELISA. Results Mice in A, B and C group developed eosinophil infiltration of the airways. Total cells and eosinophils in BALF were induced in A, B and C group. IL-4 in BALF in A ( 109.35 ± 16.46) pg/ml, B (88.87 ± 5.66) pg/ml and C ( 85.59 ± 6.05) pg/ml group were significantly different from those in D group [(23.17±2.67) pg/ml, P〈0.01]. IgE antibody in A(0.49± 0.04), B(0.41 ±0.02) and C (0.37 ± 0.04) group were significantly different from those in group D [ (0.03 ± 0.01 ), P 〈 0.01 ]; IL-4 released from spleen cultured into supernatants in A(266.20± 19.18) pg/ml, B (252.72± 15.81) pg/ml and C (243.62 ± 19.07) pg/ml group were significantly different from those in group D [ (15.99 ± 1.56) pg/ml, P 〈 0.01 ]. Conclusion The mouse model can be applied in the investigation of the immunopathogenesis of human asthma.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2005年第7期564-569,共6页 Chinese Journal of Microbiology and Immunology
基金 国家863计划(No.2002AA214011) 国家自然科学基金(No.30271226 30260101)
  • 相关文献

参考文献8

  • 1Sarpong SB, Zhang LY, Kleeberger SR. A novel mouse model of experimental asthma. Int Arch Allergy Immunol, 2003, 132(4): 346-354.
  • 2Underwood S, Foster M, Raeburm D, et al. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir, 1995, 8(12): 2104-2113.
  • 3Johnson JR, Wiley RE, Fattouh R, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med, 2004, 169(3): 378-385.
  • 4Mueller GA, Smith AM, Williams DC Jr, et al. Expression and secondary structure determination by NMR methods of the major house dust mite allergen Derp2. J Biol Chem, 1997, 272(43): 26893-26898.
  • 5Thomas WR, Hales BJ, Smith WA. Recombinant allergens for analysing T-cell responses. Methods, 2004, 32(3): 255-264.
  • 6Jin HS, Yong TS, Park JW, et al. Immune reactivity of recombinant group 2 allergens of house dust mite, Dermatophagoides pteronyssinus, and Dermatophagoides farinae. J Investig Allergol Clin Immunol, 2003, 13(1): 36-42.
  • 7Liu YH, Tsai CF, Kao MC, et al. Effectiveness of Dp2 nasal therapy for Dp2-induced airway inflammation in mice: using oral Ganoderma lucidum as an immunomodulator. J Microbiol Immunol Infect, 2003, 36(4): 236-242.
  • 8李国平,刘志刚,钟南山.支气管哮喘特异性免疫治疗与变应原疫苗的研究进展[J].国外医学(呼吸系统分册),2004,24(1):34-37. 被引量:19

二级参考文献21

  • 1Campbell D, DeKruyff RH, Umetsu DT.Allergen imnaunotherapy : novel approaches in the management of allergic diseases and ast hma. Clin lmmunol, 2000,97 : 193-202.
  • 2Bousquet J ,Lockey RF, Mailing HJ . Allergen immunotherapy:therapcuuc vaccines for allergic diseases. Allergy, 1998.53 ( 44 suppl) : 1-42.
  • 3Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Imnmnol. 1997.15:821-850.
  • 4Donovan CE, Finn PW. Immune mechanisms of childhood asthma. Thorax, 1999,54:938-946.
  • 5Korematsu S. Tanaka Y, Hosoi S, et al. C8/119S mutation of major mite allergen Derf-2 leads to degenerate secondary structure and molecular polymerization and induces potent and exclusive Thl cell differentiation. J Immunol, 2000, 165: 2895-2902.
  • 6Wierenga EA, Snoek M, de Groot C, et al. Evidence for compartmentalization of functional subsets of CD2 + T lymphocytes in atopic patienls. J Immunol, 1990, 114: 4651-4656.
  • 7Stirling RG, Chung KF. Future treatments of allergic diseases and asthma. Br Med Bull,2000,56:1037-1053.
  • 8Adkinson NF Jr, Eggleston PA ,Eney D,et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med, 1997,336 : 324-331.
  • 9Mareotte GV, Braun CM, Norman PS, et al. Effects of pcptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol.1998,101(4 Pt 1):506-513.
  • 10Giannarini L, Maggi E. Decrease of allergen-specific T-cell response induced by local nasal immunotherapy. Clin Exp Allergy, 1998,28: 404-412.

共引文献18

同被引文献119

引证文献14

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部